Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Danaher Corporation (DHR-PB)

    Price:

    1.26k USD

    ( - -9.94 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    DHR-PB
    Name
    Danaher Corporation
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    1.261k
    Market Cap
    916.756B
    Enterprise value
    175.718B
    Currency
    USD
    Ceo
    Rainer M. Blair
    Full Time Employees
    79000
    Ipo Date
    2020-05-11
    City
    Washington
    Address
    2200 Pennsylvania Avenue, NW

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Danaher Corporation

    VALUE SCORE:

    0

    Symbol
    DHR-PA
    Market Cap
    148.110B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    Qiagen N.V.

    VALUE SCORE:

    9

    Symbol
    QGEN
    Market Cap
    10.016B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Quest Diagnostics Incorporated

    VALUE SCORE:

    9

    Symbol
    DGX
    Market Cap
    23.116B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    41.005
    P/S
    6.029
    P/B
    2.821
    Debt/Equity
    0.351
    EV/FCF
    30.782
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    6.590
    Earnings yield
    0.024
    Debt/assets
    0.221
    FUNDAMENTALS
    Net debt/ebidta
    1.987
    Interest coverage
    19.385
    Research And Developement To Revenue
    0.065
    Intangile to total assets
    0.730
    Capex to operating cash flow
    0.180
    Capex to revenue
    0.047
    Capex to depreciation
    0.493
    Return on tangible assets
    0.161
    Debt to market cap
    0.124
    Piotroski Score
    7.000
    FUNDAMENTALS
    PEG
    10.532
    P/CF
    23.097
    P/FCF
    28.158
    RoA %
    4.330
    RoIC %
    5.721
    Gross Profit Margin %
    60.933
    Quick Ratio
    1.508
    Current Ratio
    1.874
    Net Profit Margin %
    14.710
    Net-Net
    -31.296
    FUNDAMENTALS PER SHARE
    FCF per share
    7.437
    Revenue per share
    34.735
    Net income per share
    5.110
    Operating cash flow per share
    9.071
    Free cash flow per share
    7.437
    Cash per share
    6.525
    Book value per share
    74.274
    Tangible book value per share
    -11.924
    Shareholders equity per share
    74.274
    Interest debt per share
    26.415
    TECHNICAL
    52 weeks high
    1.522k
    52 weeks low
    1.200k
    Current trading session High
    1.266k
    Current trading session Low
    1.260k
    DIVIDEND
    Dividend yield
    0.611%
    Payout ratio
    24.3%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    1.280
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.584
    logo

    Country
    DE
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.218

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    -138.26776%
    P/E
    -4.756

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.961
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.010

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.071
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0.0028697345%
    Payout Ratio
    13.571945999999999%
    P/E
    45.707
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.022

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    16.607

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    35.212

    No data to display

    DESCRIPTION

    Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

    NEWS